Go Pro
→ American’s Biggest Threat Is Here (From Goldco Direct, LLC) (Ad)tc pixel Free PYPD Stock Alerts

PolyPid (PYPD) Financials

PolyPid logo
$5.04 -0.19 (-3.63%)
Closing price 07/13/2026 04:00 PM Eastern
Extended Trading
$5.05 +0.01 (+0.20%)
As of 07:54 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for PolyPid

Annual Income Statements for PolyPid

This table shows PolyPid's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 5.92 -6.91 -39 -43 -40 -24 -29 -34
Consolidated Net Income / (Loss)		 5.92 -6.91 -37 -43 -40 -24 -29 -34
Net Income / (Loss) Continuing Operations		 5.92 -6.91 -37 -43 -40 -24 -29 -34
Total Pre-Tax Income 		5.92 -6.91 -37 -43 -39 -24 -29 -34
Total Operating Income		 -18 -19 -26 -43 -39 -23 -28 -33
Total Gross Profit		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Revenue		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Cost of Revenue		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses		 18 19 26 43 39 23 28 33
Selling, General & Admin Expense		 5.27 3.59 7.70 9.61 8.01 5.52 4.27 7.18
Marketing Expense		 - - - 2.98 2.89 1.20 0.95 1.98
Research & Development Expense		 13 15 19 31 28 16 23 24
Total Other Income / (Expense), net		 24 12 -11 0.54 -0.54 -0.93 -0.95 -1.20
Interest Expense		 - - - - - 0.00 0.00 0.51
Other Income / (Expense), net		 - - -11 0.54 -0.54 -0.93 -0.95 -0.69
Income Tax Expense		 - - 0.00 0.00 0.13 0.07 0.04 0.01
Basic Earnings per Share		 ($0.16) - $4.48 $68.27 $61.09 $16.99 $4.91 $2.09
Weighted Average Basic Shares Outstanding		 561.11K - 9.58M 624.05K 647.56K 1.40M 5.91M 16.35M
Diluted Earnings per Share		 $0.86 $23.69 - $68.27 $61.09 $16.93 $4.91 $2.09
Weighted Average Diluted Shares Outstanding		 613.36K 562.45K 18.49M 624.05K 647.56K 1.42M 5.91M 16.35M
Weighted Average Basic & Diluted Shares Outstanding		 - - 18.49M 18.76M 19.85M 1.65M 10.19M 18.20M

Quarterly Income Statements for PolyPid

No quarterly income statements for PolyPid are available.

Annual Cash Flow Statements for PolyPid

This table details how cash moves in and out of PolyPid's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 3.67 -3.27 0.41 5.55 -1.31 -3.46 10 -9.21
Net Cash From Operating Activities		 -17 -17 -22 -32 -34 -17 -22 -28
Net Cash From Continuing Operating Activities		 -17 -17 -22 -32 -34 -17 -22 -28
Net Income / (Loss) Continuing Operations		 5.92 -6.91 -37 -43 -40 -24 -29 -34
Consolidated Net Income / (Loss)		 5.92 -6.91 -37 -43 -40 -24 -29 -34
Depreciation Expense		 0.41 0.95 1.01 1.12 1.72 1.82 1.62 1.46
Non-Cash Adjustments To Reconcile Net Income		 -24 -10 16 4.75 4.60 4.95 3.52 5.58
Changes in Operating Assets and Liabilities, net		 1.07 -1.01 -1.69 4.35 -1.08 -0.11 1.92 -0.75
Net Cash From Investing Activities		 11 -24 -41 37 17 3.80 -0.33 -6.70
Net Cash From Continuing Investing Activities		 11 -24 -41 37 17 3.80 -0.33 -6.70
Purchase of Property, Plant & Equipment		 -3.07 -0.88 -0.78 -2.99 -1.77 -0.20 -0.08 -0.21
Purchase of Investments		 - - - -8.00 -7.00 -19 -21 -26
Other Investing Activities, net		 0.00 -23 -40 48 25 - 21 20
Net Cash From Financing Activities		 9.39 38 63 1.03 16 9.98 32 25
Net Cash From Continuing Financing Activities		 9.39 38 63 1.03 16 9.98 32 25
Repayment of Debt		 - - 0.00 0.00 -0.40 -2.74 -3.45 -7.24
Issuance of Common Equity		 0.00 0.00 63 0.00 5.01 13 36 33
Other Financing Activities, net		 0.02 0.01 0.02 1.03 0.11 0.01 0.00 0.00
Cash Interest Paid		 - - 0.00 0.00 0.73 1.04 0.95 0.56
Cash Income Taxes Paid		 - - 0.00 0.00 0.01 0.02 0.00 0.01

Quarterly Cash Flow Statements for PolyPid

No quarterly cash flow statements for PolyPid are available.

Annual Balance Sheets for PolyPid

This table presents PolyPid's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 34 76 44 26 15 25 22
Total Current Assets		 27 47 35 14 6.07 17 15
Cash & Equivalents		 3.92 4.32 9.82 8.55 5.31 16 6.40
Restricted Cash		 0.38 0.39 0.40 0.51 0.30 0.17 0.19
Inventories, net		 - - - - - - 1.11
Prepaid Expenses		 - 2.33 2.21 1.09 0.46 0.76 1.00
Other Current Assets		 23 40 22 4.04 - 0.00 6.53
Plant, Property, & Equipment, net		 6.12 5.89 8.76 9.25 7.62 6.08 5.09
Total Noncurrent Assets		 0.23 23 0.66 2.53 1.68 2.57 1.99
Other Noncurrent Operating Assets		 0.23 0.64 0.66 2.53 1.68 2.57 1.99
Total Liabilities & Shareholders' Equity		 34 76 44 26 15 25 22
Total Liabilities		 15 3.07 8.28 20 17 18 11
Total Current Liabilities		 2.58 2.88 8.08 8.55 7.29 13 7.74
Short-Term Debt		 - - 0.00 4.02 4.00 6.79 0.99
Accounts Payable		 1.58 0.97 4.14 1.14 0.77 2.41 2.86
Accrued Expenses		 1.00 1.90 3.94 2.43 1.97 2.57 2.73
Other Current Liabilities		 - - 0.00 0.96 0.54 0.92 1.16
Total Noncurrent Liabilities		 12 0.19 0.20 12 10 4.86 3.60
Long-Term Debt		 - - 0.00 7.57 6.38 0.63 0.00
Noncurrent Deferred Revenue		 - - 0.00 2.55 2.55 2.55 2.55
Other Noncurrent Operating Liabilities		 12 0.19 0.20 0.29 0.40 1.67 1.05
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -88 73 36 5.83 -2.10 7.68 11
Total Preferred & Common Equity		 -88 73 36 5.83 -2.10 7.68 11
Total Common Equity		 -88 73 36 5.83 -2.10 7.68 11
Common Stock		 5.67 205 211 220 236 275 312
Retained Earnings		 -93 -132 -175 -214 -238 -267 -302

Quarterly Balance Sheets for PolyPid

No quarterly balance sheets for PolyPid are available.

Annual Metrics And Ratios for PolyPid

This table displays calculated financial ratios and metrics derived from PolyPid's official financial filings.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth		 0.00% 1.89% -103.58% -15.69% 9.10% 41.72% -24.50% -17.68%
EBIT Growth		 0.00% -1.07% -98.65% -15.55% 7.45% 39.65% -21.79% -16.12%
NOPAT Growth		 0.00% 29.25% -41.55% -64.22% 9.87% 41.20% -22.57% -17.62%
Net Income Growth		 0.00% -216.70% -433.95% -15.55% 7.15% 39.67% -21.61% -17.73%
EPS Growth		 0.00% 2,654.65% 0.00% 0.00% 7.15% -72.29% -71.00% -57.43%
Operating Cash Flow Growth		 0.00% -4.08% -24.42% -49.96% -5.96% 49.77% -27.43% -26.94%
Free Cash Flow Firm Growth		 0.00% 0.00% -82.50% 79.99% -10.17% 9.18% -53.76% -89.48%
Invested Capital Growth		 0.00% 0.00% 219.48% -43.97% -62.95% -62.94% -119.92% 862.22%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - - - -
Gross Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profit (Net Income) Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.33% 100.29% 100.14% 100.01%
Interest Burden Percent		 -32.22% 37.20% 100.00% 100.00% 100.00% 100.00% 100.00% 101.52%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 0.00% -36.96% -80.63% -78.36% -189.32% -1,278.60% -1,038.73% -366.29%
Cash Return on Invested Capital (CROIC)		 0.00% -380.67% -165.61% -27.89% -62.44% -153.07% 0.00% -543.18%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)		 0.00% 173.39% 13.10% -78.36% -189.32% -1,278.60% -1,038.73% -366.29%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 7.88% -50.66% -118.47% -678.62% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -18 -13 -18 -30 -27 -16 -20 -23
NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)		 0.00% 283.18% -118.73% -66.94% -379.08% 168.30% -681.78% -158.52%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - -146.35% -175.07% -129.89% -192.93%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)		 -18 -19 -37 -43 -39 -24 -29 -34
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -18 -18 -36 -41 -38 -22 -27 -32
Valuation Ratios		 - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 12.75 2.95 2.24 0.00 0.26 0.00
Price to Tangible Book Value (P/TBV)		 0.00 0.00 12.75 2.95 2.24 0.00 0.26 0.00
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)		 8.45 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 11.83% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 10.57 19.62 3.73 1.76 2.30 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 2.19 -5.36 0.97 0.09
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 1.50 -3.45 0.08 0.00
Financial Leverage		 0.00 -0.23 -0.34 -0.34 -0.16 2.50 -0.49 -0.75
Leverage Ratio		 0.00 1.81 1.20 1.10 1.68 11.08 7.26 2.55
Compound Leverage Factor		 0.00 0.67 1.20 1.10 1.68 11.08 7.26 2.59
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 68.66% 122.92% 49.13% 8.26%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 21.63% 43.78% 44.93% 8.26%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 47.03% 79.14% 4.20% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 569.10% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% -469.10% 100.00% 100.00% 31.34% -22.92% 50.87% 91.74%
Debt to EBITDA		 0.00 0.00 0.00 0.00 -0.34 -0.51 -0.27 -0.03
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 -0.10 -0.26 0.31 0.17
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 -0.23 -0.33 -0.02 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 -0.47 -0.70 -0.38 -0.04
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 -0.14 -0.35 0.43 0.24
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 -0.32 -0.45 -0.03 0.00
Altman Z-Score		 0.00 -2.81 178.05 -0.29 -15.92 -26.82 -18.38 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 569.10% 116.24% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - -
Current Ratio		 0.00 10.62 16.41 4.31 1.66 0.83 1.31 1.97
Quick Ratio		 0.00 1.68 1.50 1.22 1.00 0.73 1.23 0.83
Cash Flow Metrics		 - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -27 -50 -10.00 -11 -10 -15 -29
Operating Cash Flow to CapEx		 -542.55% -1,974.74% -2,765.17% -1,082.06% -1,942.11% -8,793.88% -28,898.68% -13,275.71%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -56.93
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -54.45
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -54.86
Efficiency Ratios		 - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - -
Invested Capital		 0.00 14 46 26 9.54 3.53 -0.70 5.37
Invested Capital Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital		 0.00 14 32 -20 -16 -6.00 -4.24 6.07
Enterprise Value (EV)		 0.00 152 901 96 17 8.14 -6.38 0.00
Market Capitalization		 50 50 928 106 13 2.51 2.01 0.00
Book Value per Share		 $0.00 ($155.80) $7.59 $1.94 $0.31 ($0.11) $1.30 $0.67
Tangible Book Value per Share		 $0.00 ($155.80) $7.59 $1.94 $0.31 ($0.11) $1.30 $0.67
Total Capital		 0.00 19 73 36 19 9.14 15 12
Total Debt		 0.00 0.00 0.00 0.00 13 11 7.42 0.99
Total Long-Term Debt		 0.00 0.00 0.00 0.00 8.75 7.24 0.63 0.00
Net Debt		 0.00 -4.30 -27 -10 3.71 5.63 -8.39 -5.61
Capital Expenditures (CapEx)		 3.07 0.88 0.78 2.99 1.77 0.20 0.08 0.21
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 21 40 17 0.60 -2.83 -5.13 1.88
Debt-free Net Working Capital (DFNWC)		 0.00 25 44 27 9.67 2.78 11 8.48
Net Working Capital (NWC)		 0.00 25 44 27 5.64 -1.22 3.89 7.49
Net Nonoperating Expense (NNE)		 -24 -6.09 18 12 12 7.86 9.40 11
Net Nonoperating Obligations (NNO)		 0.00 -4.30 -27 -10 3.71 5.63 -8.39 -5.61
Total Depreciation and Amortization (D&A)		 0.41 0.95 1.01 1.12 1.72 1.82 1.62 1.46
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Adjustments		 - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $134.40 $0.00 $61.20 $16.99 $4.91 $2.09
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 319.41K 625.22K 647.56K 1.40M 5.91M 16.35M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $134.40 $68.40 $0.00 $16.93 $4.91 $2.09
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 319.41K 624.05K 661.73K 1.42M 5.91M 16.35M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 616.49K 625.22K 661.73K 1.65M 10.19M 18.20M
Normalized Net Operating Profit after Tax (NOPAT)		 -13 -13 -18 -30 -27 -16 -20 -23
Normalized NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Pre Tax Income Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt Service Ratios		 - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -65.73
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -45.07
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -66.14
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -45.48
Payout Ratios		 - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for PolyPid

No quarterly metrics and ratios for PolyPid are available.


Financials Breakdown Chart

PolyPid Financials - Frequently Asked Questions

According to the most recent income statement we have on file, PolyPid's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

PolyPid's net income appears to be on an upward trend, with a most recent value of -$34.17 million in 2025, falling from $5.92 million in 2018. The previous period was -$29.02 million in 2024. Check out PolyPid's forecast to explore projected trends and price targets.

PolyPid's total operating income in 2025 was -$32.97 million, based on the following breakdown:
  • Total Gross Profit: $0.00
  • Total Operating Expenses: $32.97 million

Over the last 7 years, PolyPid's total revenue changed from $0.00 in 2018 to $0.00 in 2025, a change of 0.0%.

PolyPid's total liabilities were at $11.33 million at the end of 2025, a 35.4% decrease from 2024, and a 24.8% decrease since 2019.

In the past 6 years, PolyPid's cash and equivalents has ranged from $3.92 million in 2019 to $15.64 million in 2024, and is currently $6.40 million as of their latest financial filing in 2025.

Over the last 7 years, PolyPid's book value per share changed from 0.00 in 2018 to 0.67 in 2025, a change of 67.1%.


Related Companies

Financial statements for NASDAQ:PYPD last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”
In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...
Paradigm Press | Sponsoredtc pixel
Trump’s $250 Bill – See Immediately
Former Goldman Sachs VP Dr. David Eifrig is warning that July 28 could trigger the biggest wealth reset in mod...
Stansberry Research | Sponsoredtc pixel
BNZI Lands a Zacks Upgrade!
Banzai International (NASDAQ: BNZI) just received a Zacks Rank 2 (Buy) upgrade, driven by improving earnings e...
Huge Alerts | Sponsoredtc pixel
American’s Biggest Threat Is Here
This feels like one of those ''where were you when Kennedy was shot'' moments. It felt like a moment in time, ...
Goldco Direct, LLC | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
Under $1 while the market panics
The new deadline for crypto’s best bill, the Clarity Act, is August 7th. That's the Senate's final session day...
Crypto 101 Media | Sponsoredtc pixel